Universal Scientific Industrial (601231.SS): 2Q26 Results Review; Key Takeaways of 2Q26 Earnings Call

Research evidence excerpt

Universal Scientific Industrial (601231.SS): 2Q26 Results Review; Key Takeaways of 2Q26 Earnings Call

able distributor or authorized participant, the

exchange upon which an ETF is listed and/or from the applicable website of the applicable ETF issuer. The value of the

investments and any accruing income may fall or rise. Any past performance, prediction or forecast is not indicative of future or

likely performance. Any information on ETFs contained herein is provided strictly for illustrative purposes and should not be

deemed an offer to sell or a solicitation of an offer to purchase units of any ETF either explicitly or implicitly. The opinions

expressed are those of the authors and do not necessarily reflect the views of ETF issuers, any of their agents or their affiliates.

Citigroup Global Markets India Private Limited and/or its affiliates may have, from time to time, actual or beneficial ownership

of 1% or more in the debt securities of the subject issuer.

Please be advised that pursuant to Executive Order 13959 as amended (the “Order”), U.S. persons are prohibited from

investing in securities of any company determined by the United States Government to be the subject of the Order. This

research is not intended to be used or relied upon in any way that could result in a violation of the Order. Investors are

encouraged to rely upon their own legal counsel for advice on compliance with the Order and other economic sanctions

programs administered and enforced by the Office of Foreign Assets Control of the U.S. Treasury Department.

This communication is directed at persons who are "Eligible Clients" as such term is defined in the Israeli Regulation of

Investment Advice, Investment Marketing and Investment Portfolio Management law, 1995 (the "Advisory Law").